TP028/#658 Rationale and Study Design of the KOV-HIPEC-02 Trial: a Randomized, Multicenter, Open-Label Phase III Trial of Hyperthermic Intraperitoneal Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer
E-Posters (Trials In Progress)（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined